Vanda Pharmaceuticals Reports Third Quarter 2012 Results
Vanda Pharmaceuticals Reports Third Quarter 2012 Results
Filed under: drug abuse treatment cost analysis program
7, 2012 — /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced financial and …
Read more on Sacramento Bee
Human enhancement and the future of work
Filed under: drug abuse treatment cost analysis program
Cost and cost–benefit analysis are clearly key factors in determining who funds provision, which in turn will impact on equality and justice. … •Cognition enhancing drugs used to treat individuals with neuropsychiatric disorders could also improve …
Read more on Next Big Future
Meds a good 'first step' for treating alcoholism
Filed under: drug abuse treatment cost analysis program
Two drugs commonly used to treat alcoholism may be appropriate for people in different stages of recovery, a new analysis confirms – likely because they work differently in the brain. The drugs, acamprosate (marketed as Campral) and naltrexone (ReVia …
Read more on Fox News